Mhesin, H., Gataa, I. (2024). Comparison between Bleomycin Foam and Liquid Injection in Treatment of Maxillofacial Low Flow Vascular Malformations. , 23(3), 354-360. doi: 10.52573/ipmj.2024.140000
Hiba Ali Mhesin; Ibrahim Saeed Gataa. "Comparison between Bleomycin Foam and Liquid Injection in Treatment of Maxillofacial Low Flow Vascular Malformations". , 23, 3, 2024, 354-360. doi: 10.52573/ipmj.2024.140000
Mhesin, H., Gataa, I. (2024). 'Comparison between Bleomycin Foam and Liquid Injection in Treatment of Maxillofacial Low Flow Vascular Malformations', , 23(3), pp. 354-360. doi: 10.52573/ipmj.2024.140000
Mhesin, H., Gataa, I. Comparison between Bleomycin Foam and Liquid Injection in Treatment of Maxillofacial Low Flow Vascular Malformations. , 2024; 23(3): 354-360. doi: 10.52573/ipmj.2024.140000

Comparison between Bleomycin Foam and Liquid Injection in Treatment of Maxillofacial Low Flow Vascular Malformations

Iraqi Postgraduate Medical Journal
Volume 23, Issue 3, July 2024, Pages 354-360    PDF (502.86 K)
Document Type: Research Paper
DOI: 10.52573/ipmj.2024.140000
Authors
Hiba Ali Mhesin1; Ibrahim Saeed Gataa* 2
1Alwasity Center of Reconstructive Surgery / Baghdad / Iraq
2University of Warith Al-anabyiaa
Abstract
ACKGROUND:
Vascular anomalies represent a wide range of vascular pathology classified by flow velocity. Venous malformations are the most frequent kind of head and neck vascular malformation that cause functional and cosmetic disturbances. Injection sclerotherapy is the initial therapeutic choice for venous abnormalities.
AIMS OF STUDY:
To compare the effects of bleomycin foam and liquid in treatment of maxillofacial venous malformation regarding the dose, size of the lesion and number of treatment sessions.
PATIENT AND METHOD:
This study involved 20 patients (11 females, 9 males) with an age range (9- 47) years, had venous malformation in the head and neck region presented to Maxillofacial Surgical department in Alwasity hospital / Baghdad, from Jan 2021 to April 2022.
Patients were divided into two equal groups randomly. The odd number of patients (group A) were treated by bleomycin foam injection while the even number group (B) were injected by bleomycin liquid.
RESULTS:
The results showed in group (A), 6 patients were in scale 4 with an excellent response and 4 patients were in scale 3 good response . In group (B) group, 3 patients were in scale 4 excellent response, 6 patients were in scale 3 good response and one patient was in scale2 fair response.
CONCLUSION:
Bleomycin liquid and foam injections are effective sclerosing agent for vascular malformation Treatment. Bleomycin foam sclerotherapy was an effective with decrease in number of treatment sessions and less dose of bleomycin medication. Data from the present study suggested more effective treatment outcomes in female than male.
Keywords
Bleomycin Foam,,; ,،Sclerotherapy,,; ,،Maxillofacial,,; ,،Vascular Malformations
References
  1. Mulligan P. R., Prajapati H. J. S., Martin L. G. & Patel T. H. Vascular anomalies: classification, imaging characteristics and implications for interventional radiology treatment approaches. Br J Radiol, 2014 ;87:103.‏
  2. Malay S., & Chung K. C. The choice of controls for providing validity and evidence in clinical research. Plast Rconstr Surg, 2012;130: 959.‏
  3. Gibson C. R., & Barnacle A. M. Vascular anomalies: special considerations in children. CVIR, 2020;3:1-13.‏
  4. Memon Y., Malik N. I., Anjum N., Ahmed S. K., & Saeed S. Ultrasound-guided Intralesional Bleomycin Injection (IBI) for treatment of cutaneous hemangiomas and vascular malformations. J Global Rad, 2016;2:2.‏
  5. Mulliken J. B., & Glowacki J. Hemangiomas and vascular malformations in infants and children: a classification based on endothelial characteristics. Plast Recontr Surg, 1982;69:412-20.‏
  6. Steiner J. E., & Drolet B. A. Classification of vascular anomalies: an update. Semin  Intervent Radiol 2017;34:225-32.
  7. Cha J. G., Lee J., Lee S.Y., Chung H. Y., Lee S. J., Huh S.& Hong J. (2022). Safety and Efficacy of Bleomycin Slow Infusion Sclerotherapy Using a Syringe Pump for Microcystic and Mixed Lymphatic Malformations. CardioVascular and Interventional Radiology,2022; 45:1288-94.‏
  8. Kollipara R., Dinneen L., Rentas K. E., Saettele M. R., PatelS. A., Rivard D. C., & Lowe L. H. Current classification and terminology of pediatric vascular anomalies. Am J Roentgenology 2013;201:1124-35.‏
  9. Shatzkes D.R. Vascular anomalies: Description, classification and nomenclature. Applied Radiology,2018;9:14.
  10. Liu Y., Denggao L, Yixiang W., Wei Z., & Fuyun Z. Clinical study of sclerotherapy of maxillofacial venous malformation using absolute ethanol and pingyangmycin,” J Oral Maxillofac Surg, 2009;67:98-104.
  11. Boon L.M., Ballieux F. & Vikkula M. Pathogenesis of vascular anomalies. Clinic Plast Surg,2011; 38:7-19.
  12. Achauer BM, Chang CJ, Vander Kam VM. Management of hemangioma of infancy: review of 245 patients. Plast Reconstr Surg. 1997;99:1301–8.
  13. Helal, H. & Mahmoud, N.Effect of foam and liquid bleomycin in the management of venous malformations in head and neck region: A comparative study. Plast Reconstr Aesthet Surg 2020 ;73:90-97.
  14. Mahmoud N. Effect of Foam and Liquid Bleomycin in the Management of Venous Malformations in Head and Neck Region. A Comparative Study. Egyp J Plast Recon Surg, 2020;43;401-8.
  15. Haq UL., Mitchell F., Tekes S.& Weiss A. Bleomycin Foam Treatment of Venous Malformations: A Promising Agent for Effective Treatment with Minimal Swelling. J Vasc Interv Radiol ,2015; 26:1484-93.
  16. Zhang H., Chen A., Zhang F. & Liu S. Modified Method to Increase the Volume and Stability of Bleomycin Foam: An Experimental Study. Derma Surg,2019; 46:1030-34.
  17. Azene E., Mitchell S., Radvany M., Agrawal N., Eisele D. & Weiss, C. Foamed bleomycin sclerosis of airway venous malformations: The role of interspecialty collaboration. Laryngoscope, 2016;126:2726-32.
  18. Bhardwaj A., Gupta S., Moirangthem R., Anant A. & Bharadwaj N.2017. Intralesional Bleomycin as Therapeutic Modality for Low-flow Venous Malformations: Treatment on Outpatient Basis. IJHNS, 2017; 8:112-17.
  19. Murray V, Chen J &Chung L. The interaction of the metallo-glycopeptide anti-tumour drug bleomycin with DNA. Int J Mol Sci. 2018;19:1372.
 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Statistics
Article View: 229
PDF Download: 87


Journal Management System. Powered by iJournalPro.com